DanStevenVeljovichMD

PubMed

• 34 citations
  Cetuximab in Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Ovarian Cancer Without KRAS, NRAS, or BRAF Mutations: Results from the Targeted Agent and Pro...
  Julie Gottlieb Fisher, David Tait, Elizabeth Garrett-Mayer, Susan Halabi, Pam K. Mangat
  Targeted Oncology. 2020-10-22
• 89 citations
  Surgical and oncologic outcomes after robotic radical hysterectomy as compared to open radical hysterectomy in the treatment of early cervical cancer.
  Chirag A. Shah, Tiffany L. Beck, John B. Liao, Nadia V. Giannakopoulos, Dan S. Veljovich
  Journal of Gynecologic Oncology. 2017-07-03
• 46 citations
  A prospective investigation of fluorescence imaging to detect sentinel lymph nodes at robotic-assisted endometrial cancer staging
  Pamela J. Paley, Dan S. Veljovich, Joshua Z. Press, Christina Isacson, Ellen S. Pizer
  American Journal of Obstetrics and Gynecology. 2016-07-01

Journal Articles

• Surgical and oncologic outcomes after robotic radical hysterectomy as compared to open radical hysterectomy in the treatment of early cervical cancer  
  Shah CA, Beck T, Liao JB, Giannakopoulos NV, Veljovich D, Paley P, J Gynecol Oncol, 1/1/2017
• A prospective evaluation of fluorescence imaging to detect sentinel lymph nodes at robotic-assisted endometrial cancer staging  
  Paley PJ, Veljovich DS, Press J, Isacson C, Pizer E, Shah C, Am J Obstet Gynecol, 1/29/2015
• Unexpected gastrointestinal toxicity from Doxetaxel/Carboplatinum/Erlotinib followed by maintenance Erlotinib treatment from newly diagnosed stage III/IV ovarian cance...  
  Holmberg, LA, Goff B, Veljovich D, Gynecologic Oncology, 1/1/2011

Books/Book Chapters

• Re-operative Pelvic Surgery 
  Chapter: Re-Operative laparoscopic surgery in gynecologic oncology. 
  Veljovich DEditors: William A. Peters, Richard P. Billingham, Kathleen Kobashi.Springer Verlag2009

Abstracts/Posters

• Phase IB/II with expansion of patients at the MTD study of olaparib plus weekly (metronomic) carboplatinum and paclitaxel in relapsed ovarian cancer patients.
  Rivkin SE, Moon J, Iriarte D, Sloan H, Wiseman C, Klee M, Ference K, Drescher C, Veljovich D, BonDurant A, Peters W, Jiang P, Goodman G, Park M, Fern M, Shah C, Johnst..., 11th Biennial Ovarian Cancer Research Symposium, Seattle, WA, 1/13/2016
• Surgical and oncologic outcomes after robotic radical hysterectomy as compared to open radical hysterectomy in the treatment of early cervical cancer.
  Chirag Shah, Pacific Coast Obstetrical and Gynecological Society 82nd Annual Meeting, Kahuku, Oahu, HI, 1/2/2015
• Phase Ib/II expansion of patients at the MTD study of olaparib plus weekly (metronomic) carboplatinum and paclitaxel in relapsed ovarian cancer patients.
  Saul E. Rivkin, Desiree Iriarte, Heather Sloan, Cara Wiseman, James Moon, Gary Goodman, Amy BonDurant, Dan Veljovich, Peter Jiang, Tanya Wahl, Chirag Shah, Charles Dre..., J Clin Oncol, 2015 ASCO Annual Meeting, 1/1/2015
• Surgical and oncologic outcomes after robotic radical hysterectomy for cervical cancer.
  Chirag Shah, Western Association of Gynecologic Oncologists 42nd Annual Meeting, West Seattle, Seattle, WA, 1/27/2013
• Phase 2 prospective study of weekly Topotecan and bevacizumab in platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer (OC).
  Veljovich D, SGO 40th Annual Meeting on Women's Cancer, San Antonio, TX, 1/5/2009
• Genistein, a plant-derived phytoestrogen, inhibits growth in murine endometrial carcinoma xenografts at a threshold dietary level.
  Veljovich D, The Society of Gynecologic Oncologists 32nd Annual Meeting, Opryland Hotel, Nashville, TN, 1/1/2001
• Genistein, a plant-derived phytoestrogen, inhibits growth in murine endometrial carcinoma xenografts at a threshold dietary level.
  Veljovich D, Glaxo Smith Kline 2001 National Gynecologic Oncology Fellows' Forum, Tucson, AZ, 1/1/2001
• The soy product genistein inhibits growth and invasion while increasing apoptosis of ovarian cancer in vitro.
  Veljovich D, The 2000 National Gynecologic Oncology Fellows' Forum, Rancho Bernardo Inn, San Diego, CA, 1/24/2000
• The soy product genistein inhibits growth and invasion while increasing apoptosis of ovarian cancer in vitro.
  Veljovich D, Gyn Oncology, The Society of Gynecologic Oncologists 31st Annual Meeting, San Diego Marriott, San Diego, CA, 1/8/2000
• The isoflavone genistein inhibits growth and invasion of human endometrial cancer cell lines in vitro.
  Veljovich D, Gyn Oncology, The Society of Gynecologic Oncologists 30th Annual Meeting, San Francisco Hyatt Embarcadero, San Francisco, CA, 1/22/1999
• Genistein inhibits growth and invasion of human endometrial cancer cell lines in vitro.
  Veljovich D, J of the Soc of Gynecol Invest, Society for Gynecologic Investigation 46th Annual Meeting, Atlanta Marriott Marquis, Atlanta, GA, 1/12/1999
• Join now to see all

Lectures

• Lynparza Maintenance Therapy for Recurrent Ovarian Cancer. 
  Imperial Restaurant, Portland, OR - 1/28/2017
• Ovarian Cancer Screening Controversies 
  The Rainier Club, Seattle, WA - 1/24/2017
• Avastin-Based Therapy for Recurrent Ovarian Cancer. 
  Andina Restaurant, Portland, OR - 1/20/2017
• ZEJULA: The first and only once-daily oral PARP inhibitor approved for use regardless of BRCA status. 
  Milford Fish House, Spokane, WA - 1/17/2017
• "Less is More": The Evolution of Tailoring Radical Surgery 
  Hyatt Olive 8, Seattle, WA - 1/12/2017
• Exploring the Implications of BRCA Mutations and Parp Inhibition in Advanced Ovarian Cancer. 
  Water Street Cafe, Olympia, WA - 1/10/2017
• Exploring the Implications of BRCA Mutations and Parp Inhibition in AdvancedOvarian Cancer. 
  Aqua by El Gaucho, Seattle, WA - 1/6/2017
• Introducing ZEJULA (niraparib) capsules. 
  John Howie Steak, Bellevue, WA - 1/3/2017
• Ovarian Cancer Risk Factors, Risk Reduction, Screening, and Genetic Testing. 
  PACCAR Auditorium, Bellevue, WA - 1/25/2016
• Bevacizumab in Ovarian and Cervical Carcinoma. 
  Bernadin's Fine Dining, Winston Salem, NC - 1/17/2016
• What I Wish My Surgical Colleagues Knew About Gynecology. 
  Hyatt at Olive 8, Seattle, WA - 1/5/2016
• Surgical and Medical Innovations in Gynecologic Oncology: What a Difference a Decade Makes. 
  Washington Athletic Club-Seattle, WA - 1/19/2015
• Hereditary Cancer Family History and Testing Outcomes in an OB/GYN Population 
  Marcus Whitman Hotel & Conference Center, Walla Walla, WA - 1/1/2013
• Robotic Surgery for Ovarian Carcinoma. 
  Balboa Bay Club, Newport Beach, CA - 1/1/2012
• Total Laparoscopic Hysterectomy: Comparison of Costs and Clinical Outcomes Between Robotic and Traditional Laparoscopic Surgery 
  Sunriver, OR - 1/17/2011
• Robotic Sacral Colpopexy: Initial Experience with Comparison to Abdominal Sacral Colpopexy. 
  Hapuna Prince Hotel, Kohala Coast, HI - 1/30/2010
• Robotic Surgery for Ovarian Carcinoma: Initial Experience. 
  Seattle University, Seattle, WA - 1/29/2010
• Endometrial Cancer, What a Difference a Decade Makes; Robotic Surgery: Fad or the Future; Recognition and Repair of Urologic and Gastrointestinal Surgical Injuries. 
  Suncadia Resort, Cle Elum, WA - 1/25/2010
• Robotic Surgery: Technology for Now and for the Future. 
  Valley Medical Center - 1/26/2009
• Robotic Gynecologic Surgery 
  The Hotel Captain Cook, Anchorage, AK - 1/24/2009
• GYN Cancers 2009: What is the Current Role of Robotic Surgery? 
  UW-Tacoma Campus - 1/18/2009
• Robotic Surgery and Endometrial Cancer: Future Directions in Gynaecological Oncology. 
  The Grand Hyatt Belgrade, Belgrade, Serbia - 1/14/2009
• Express Postgraduate Course 2: Robotics: Surgical Innovation or Tomfoolery. A debate and practice impact analysis. 
  San Antonio, TX - 1/5/2009
• Robotic Surgery in Gynecology. 
  The Westin Seattle - 1/18/2008
• Robotic Surgery in Gynecologic Oncology: Fad or the Future. 
  Park City Marriott, Park City, UT - 1/15/2008
• Join now to see all

Other

• Modified posterior exenteration in the treatment of ovarian carcinoma. 
  Veljovich D, SGO Film Festival, The Society of Gynecologic Oncologists 31st Annual Meeting
  San Diego Marriott, San Diego, CA - 1/8/2000